InsiderTrades

Form 4 for DT Dynatrace, Inc.

Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-25 · accession 0001773383-24-000227 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-26 2024-11-25 DT Dollentz-Scharer Matthias EVP, Chief Customer Off S - Sale+OE $55.31 -66.0K 100.4K -40% -$3.65M
DM 2024-11-26 2024-11-25 DT Dollentz-Scharer Matthias EVP, Chief Customer Off M - OptEx $30.46 +46.0K 146.4K +46% +$1.40M
DM 2024-11-26 2024-11-25 DT Dollentz-Scharer Matthias EVP, Chief Customer Off M - OptEx $0.00 -46.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-25 S D 20,000 $55.22 100,387 D — — (F1) The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.20 to $55.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-11-25 M A 6,937 $16.00 107,324 D — —
3 Common Common Stock 2024-11-25 M A 39,050 $33.03 146,374 D — —
4 Common Common Stock 2024-11-25 S D 45,987 $55.35 100,387 D — — (F2) The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.32 to $55.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (Right to Buy) 2024-11-25 M D 39,050 $0.00 0 D $33.03 · — to 2030-05-15 39,050 Common Stock (F4) Stock Options granted on May 15, 2020, 25% vested and become exercisable on May 15, 2021, and the remainder vested in 12 equal quarterly installments.
6 Derivative Stock Option (Right to Buy) 2024-11-25 M D 6,937 $0.00 0 D $16.00 · — to 2029-07-31 6,937 Common Stock (F3) Stock Options granted on July 31, 2019, 25% vested and became exercisable on August 15, 2020, and the remainder vested in 12 equal quarterly installments thereafter.